Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy

High-grade neuroepithelial tumor of the central nervous system with BCOR alteration (HGNET-BCOR) is a rare, highly malignant tumor. At the time of this publication, no standard protocol exists to treat this tumor entity. In this work, we tested the responsiveness of the primary culture PhKh1 derived...

Descripción completa

Detalles Bibliográficos
Autores principales: Paret, Claudia, Russo, Alexandra, Otto, Henrike, Mayer, Arnulf, Zahnreich, Sebastian, Wagner, Wolfgang, Samuel, David, Scharnhorst, David, Solomon, David A., Dhall, Girish, Wong, Kenneth, Bender, Hannah, Alt, Francesca, Wingerter, Arthur, Neu, Marie A., Beck, Olaf, Prawitt, Dirk, Eder, Stefan, Henninger, Nicole, El Malki, Khalifa, Lehmann, Nadine, Backes, Nora, Roth, Lea, Seidmann, Larissa, Sommer, Clemens, Brockmann, Marc A., Staatz, Gundula, Schmidberger, Heinz, Faber, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768397/
https://www.ncbi.nlm.nih.gov/pubmed/29371980
http://dx.doi.org/10.18632/oncotarget.23174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768397/
https://www.ncbi.nlm.nih.gov/pubmed/29371980
http://dx.doi.org/10.18632/oncotarget.23174

Ejemplares similares